Search

CHPA launched a new podcast – CHPA Chat – providing stories and insights from staff, industry leaders, academics, and healthcare providers about the trends and issues facing the consumer healthcare space.

In a new letter, ACI and CHPA call on FDA to withdraw its temporary guidance for the manufacturing of alcohol-based hand sanitizer products.

The American Herbal Products Association (AHPA), the Consumer Healthcare Products Association (CHPA), the Council for Responsible Nutrition (CRN), and the United Natural Products Alliance (UNPA) commemorate the 100th meeting of the Dietary Supplement Trade Associations (DSTA).

The Consumer Healthcare Products Association (CHPA) released a statement commending the House of Representatives following its passage of H.R. 1996, the SAFE Banking Act.

As in past years, the 2021 summit will feature updates and insights from top FDA officials, including the Office of Dietary Supplement Programs, and industry experts, with a focus on dietary supplement regulatory compliance.

In a major victory for consumer health, today Mississippi has repealed an 11-year-old law that banned over-the-counter (OTC) sales of certain medicines for colds and allergies containing the decongestant pseudoephedrine (PSE).

CHPA congratulates Patrizia Cavazzoni on her recent appointment as director of FDA’s Center for Drug Evaluation and Research (CDER).

Best practices for consumers looking to make evidence-informed decisions when shopping for dietary supplements, including avoiding red-flag ingredients such as SARMs.

The types of evidence used to monitor dietary supplement safety, including adverse event reports, emergency room visits and poison control center data.

Expert insights on the importance of proactive health maintenance, including addressing nutrient deficiencies that increase risk of infection and disease.